Company intelligence / Profile preview
Newish Technology (Beijing) Co., Ltd.
Beijing, Beijing Shi, Chinanewishes.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Currently conducting clinical trials for multiple vaccine candidates including NWRD09 (HPV-16 targeted mRNA vaccine) in HPV-16 positive and HPV-16 related cervical, vaginal, and vulvar intraepithelial neoplasia patients and HPV-16 related cervical cancer patients. Also testing NWRD08 in HPV16/18 positive cervical HSIL patients.
- Therapeutic areas
- OncologyInfectious Diseases
- Modalities
- DNA vaccinemRNA vaccineTherapeutic vaccineProphylactic vaccineTCR therapy
- Industry
- Biotech
02
Drug pipeline
4 assets3 more assets in the full pipeline.
Beyond the preview
Go deeper on Newish Technology (Beijing) Co., Ltd..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Newish Technology (Beijing) Co., Ltd..